⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Galectin Therapeutics Inc.

$3.58
+0.04 (+1.13%)

Volume:

135.655K ($485.54K)

Market Capitalization:

$361.04M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Galectin Therapeutics Market Segments

Regular Trading Hours

-0.03(-0.83%)
Open$3.61
Close$3.58
Low$3.45
Low Change-0.16 (-4.50%)
High$3.70
High Change+0.09 (+2.49%)
Range$0.25
Volume134.345K
Dollar Volume$480.96K

Premarket

+0.00(+0.00%)
Open$3.50
Close$3.50
Low$3.50
Low Change0.00 (0.00%)
High$3.50
High Change+0.00 (+0.00%)
Range$0.00
Volume1.31K
Dollar Volume$4.59K

Overnight

*No Trades in Segment

After Hours Yesterday

-0.10(-2.71%)
Open$3.54
Close$3.44
Low$3.44
Low Change-0.10 (-2.71%)
High$3.54
High Change+0.00 (+0.00%)
Range$0.10
Volume18.591K
Dollar Volume$64.03K

Regular Trading Hours Yesterday

+0.17(+5.04%)
Open$3.37
Close$3.54
Low$3.27
Low Change-0.10 (-2.97%)
High$3.56
High Change+0.19 (+5.64%)
Range$0.29
Volume107.348K
Dollar Volume$380.01K

Premarket Yesterday

-0.09(-2.76%)
Open$3.26
Close$3.17
Low$3.17
Low Change-0.09 (-2.76%)
High$3.31
High Change+0.05 (+1.53%)
Range$0.14
Volume4.204K
Dollar Volume$13.33K

Galectin Therapeutics Top Trades

Galectin Therapeutics's top trade so far today returned +5.71%, while the top short trade returned -4.50%.

Galectin Therapeutics Moving Averages

5 Day Moving Average (SMA5)$3.33
10 Day Moving Average (SMA10)$3.43
20 Day Moving Average (SMA20)$3.59
50 Day Moving Average (SMA50)$3.82
100 Day Moving Average (SMA100)$3.71
200 Day Moving Average (SMA200)$3.21

Galectin Therapeutics Statistics

Average Volume (30 Days)298.79K
P/E Ratio (Current)-14.07
EPS (Current)-$0.28
Dividend Yield0.00%
Free Cash Flow-$15.89M
Cash Ratio0.09
Current Ratio0.10
Quick Ratio0.10
Debt to Equity-0.24
Enterprise Value$417.12M
EV to EBITDA-26.70
EV to Sales—
Price to Book-2.87
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-1.89%
Return on Equity0.20%

Galectin Therapeutics Stock Splits

There has been 1 stock split for Galectin Therapeutics (GALT). The reverse stock split occured on March 23, 2012 and reduced the outstanding shares at a ratio of 6:1.

DateTypeRatio
Mar 23, 2012Reverse6:1

Galectin Therapeutics Dividends

There have been no dividends for Galectin Therapeutics (GALT).